Metabolic Research Compound
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist — 10mg lyophilized powder. Analytical-grade research standard.
What is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist representing an advanced class of incretin-based research compounds. It simultaneously targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it an important analytical reference for multi-receptor metabolic research.
VELTRIDE supplies Tirzepatide at ≥99% HPLC purity with a Certificate of Analysis available for every lot, shipped discreetly Canada-wide.
Key Research Applications
- Dual GIP/GLP-1 receptor co-agonism binding studies
- Comparative incretin receptor pathway analysis
- Metabolic pathway modeling with dual receptor targets
- Insulin secretion augmentation mechanism research
- Adipogenesis and lipid metabolism studies
- Hepatic glucose output regulation research
- Incretin-based compound structural characterization
Frequently Studied With
⚠ Research Use Only Disclaimer All VELTRIDE products are strictly for in-vitro laboratory and analytical research purposes only. Not for human consumption, veterinary use, or medical treatment. Not approved by Health Canada for therapeutic use. By purchasing, you confirm you are 19+ and a qualified researcher using these compounds in a controlled research setting.